Inspection·December 18, 2025

F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review, the facility failed to provide pharmaceutical services, consistent with professional standards of practice, to ensure medication administration for 1 resident reviewed for intravenous medications, out of a total sample of 25 residents, (#4). Findings:Review of the medical record revealed resident #4 was admitted to the facility on [DATE] with diagnoses including metabolic encephalopathy, type 2 diabetes, sepsis due to E. Coli, stage 3 chronic kidney disease, acute prostatitis, adult failure to thrive and prostate abscess.Review of the Order Summary Report revealed resident #4 had physician orders dated 11/19/25 for Piperacillin Sodium-Tazobactam Sodium Intravenous Solution Reconstituted 4.5 GM intravenously every 8 hours for urosepsis and prostatitis.A prostate abscess is a localized collection of purulent fluid (discharge from a wound which often indicates infection) within the prostate, often forming as a complication of acute prostatitis. A prostatic abscess can cause severe urosepsis or a urinary tract infection that spreads to the bloodstream, which can result in serious complications including death. (retrieved on 12/19/25 https://www.ncbi.nlm.nih.gov/sites/books/NBK551663/)Review of resident #4's medical record revealed he had a care plan for intravenous (IV) antibiotic therapy related to urosepsis, initiated on 11/25/25. The interventions instructed nurses to administer antibiotic medications as ordered by the physician.Review of electronic Medication Administration Record (eMAR) revealed the following:On 11/20/25 at 10:00 PM, the MAR was noted to be ‘blank' and no documentation of the medication being administered.On 11/21/25 at 6:00 AM, the MAR was noted to be ‘blank' and no documentation of the medication being administered.On 11/25/25 at 6:00 AM, the MAR was noted to be ‘blank' and no documentation of the medication being administered.On 11/25/25 at 2:00 PM, the MAR was noted to be ‘blank' and no documentation of the medication being administered.On 11/27/25 at 10:00 PM, the MAR was noted to be ‘blank' and no documentation of the medication being administered.On 11/28/25 at 10:00 PM, the MAR was noted to be ‘blank' and no documentation of the medication being administered.On 12/1/25 at 6:00 AM, the MAR was noted to be ‘blank' and no documentation of the medication being administered.On 12/2/25 at 6:00 AM, the MAR was noted to be ‘blank' and no documentation of the medication being administered.On 12/4/25 at 6:00 AM, the MAR was noted to be ‘blank' and no documentation of the medication being administered.On 12/9/25 at 6:00 AM, the MAR was noted to be ‘blank' and no documentation of the medication being administered. On 12/18/25 at 10:10 AM, the Director of Nursing (DON) revealed that the facility reopened at the end of October, and she had started in this position at the beginning of December. She acknowledged resident #4's eMAR does not reflect the intravenous medication was administered. The DON said at this facility only Registered Nurses (RN) may administer IV medications unless a Licensed Practical Nurse is IV certified. She stated she assumed the RN administered the medication and ‘forgot' to document the medication was administered. She acknowledged the IV medication administration could not be verified for resident #4. Review of the facility policy titled Administration of (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 3 Event ID: 105974 Printed: 05/28/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 105974 B. Wing A. Building (X3) DATE SURVEY COMPLETED 12/18/2025 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Life Care Center of Orlando 3211 Rouse Road Orlando, FL 32817 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)